Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study ; volume:38 ; number:12 ; day:7 ; month:10 ; year:2024 ; pages:1017-1027 ; date:12.2024
CNS drugs ; 38, Heft 12 (7.10.2024), 1017-1027, 12.2024
- Creator
-
Tepper, Stewart J.
Albrecht, Detlef
Ailani, Jessica
Kirby, Louis
Strom, Shannon
Rapoport, Alan M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-024-01118-8
- URN
-
urn:nbn:de:101:1-2501252112524.086755237786
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tepper, Stewart J.
- Albrecht, Detlef
- Ailani, Jessica
- Kirby, Louis
- Strom, Shannon
- Rapoport, Alan M.
- SpringerLink (Online service)
Other Objects (12)
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate
Effects of excipients in nasal powder formulations for systemic drug delivery
Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
Nasal Powder Formulations : In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate
Effects of excipients in nasal powder formulations for systemic drug delivery
Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
Nasal Powder Formulations : In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate
Effects of excipients in nasal powder formulations for systemic drug delivery
Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs